Tim P. Green

<i>N</i>-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5- (tetrahydro-2<i>H</i>-pyran-4-yloxy)quinazolin-4-amine, a Novel, Highly Selective, Orally Available, Dual-Specific c-Src/Abl Kinase Inhibitor

Laurent Hennequin, J M Allen, J. Breed et al. · Journal of Medicinal Chemistry · 2006 · 367 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

Elevated Src activity promotes cellular invasion and motility in tamoxifen resistant breast cancer cells

Stephen Hiscox, L. Morgan, Tim P. Green et al. · Breast Cancer Research and Treatment · 2005 · 273 citations

Medicine, Cell Biology, Oncology +16

Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530

Tim P. Green, Mike Fennell, Robin Whittaker et al. · Molecular Oncology · 2009 · 256 citations · Full text

Medicine, Oncology, Pharmacology +10

Discovery of a New Class of Anilinoquinazoline Inhibitors with High Affinity and Specificity for the Tyrosine Kinase Domain of c-Src

Patrick A. Plé, Tim P. Green, Laurent Hennequin et al. · Journal of Medicinal Chemistry · 2004 · 167 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Saracatinib Impairs Head and Neck Squamous Cell Carcinoma Invasion by Disrupting Invadopodia Function

Amanda G. Ammer, Laura C. Kelley, Karen E. Hayes et al. · Journal of Cancer Science & Therapy · 2009 · 79 citations · Full text

Medicine, Oncology, Pharmacology +17